Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Philippe, Caenepeel"'
Autor:
Florencia Carbone, Alain Vandenberghe, Lieselot Holvoet, Hubert Piessevaux, Joris Arts, Philippe Caenepeel, Dirk Staessen, Philippe Vergauwe, Philippe Maldague, Thierry De Ronde, Fabien Wuestenberghs, Vincent Lamy, Veronique Lefebvre, Pascale Latour, Tim Vanuytsel, Michael Jones, Jan Tack
Publikováno v:
Neurogastroenterology & Motility. 34
Itopride, a mixed D2 antagonist and cholinesterase inhibitor, has prokinetic effects on gastric motility. The Leuven Postprandial Distress Scale is a validated patient-reported outcome instrument for functional dyspepsia (FD) postprandial distress sy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e09bb18c2ab58e2da1e705b8ec16de36
https://doi.org/10.1111/nmo.14337
https://doi.org/10.1111/nmo.14337
Autor:
Filip, Baert, Elien, Glorieus, Cathérine, Reenaers, Geert, D'Haens, Harald, Peeters, Dennis, Franchimont, Olivier, Dewit, Philippe, Caenepeel, Edouard, Louis, Gert, Van Assche, L, Terriere
Publikováno v:
Journal of Crohn s & colitis, 7(2), 154-160. Elsevier
BACKGROUND AND AIMS: Adalimumab is efficacious in inducing and maintaining remission in Crohn's disease but dose escalation is needed in 30-40% after 1 year. Attempts for dose de-escalation have not been studied. This study aimed to assess the need f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::957a70c69fb5114f67a23a0bd6e4bc3b
https://pubmed.ncbi.nlm.nih.gov/22537637
https://pubmed.ncbi.nlm.nih.gov/22537637